Cargando…
Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
Background: Quantitative electroencephalography (qEEG) has been suggested as a biomarker for cognitive decline in Parkinson’s disease (PD). Objective: Determine if applying a wavelet-based qEEG algorithm to 21-electrode, resting-state EEG recordings obtained in a routine clinical setting has utility...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761986/ https://www.ncbi.nlm.nih.gov/pubmed/35046794 http://dx.doi.org/10.3389/fnagi.2021.804991 |
_version_ | 1784633659990474752 |
---|---|
author | Novak, Kevin Chase, Bruce A. Narayanan, Jaishree Indic, Premananda Markopoulou, Katerina |
author_facet | Novak, Kevin Chase, Bruce A. Narayanan, Jaishree Indic, Premananda Markopoulou, Katerina |
author_sort | Novak, Kevin |
collection | PubMed |
description | Background: Quantitative electroencephalography (qEEG) has been suggested as a biomarker for cognitive decline in Parkinson’s disease (PD). Objective: Determine if applying a wavelet-based qEEG algorithm to 21-electrode, resting-state EEG recordings obtained in a routine clinical setting has utility for predicting cognitive impairment in PD. Methods: PD subjects, evaluated by disease stage and motor score, were compared to healthy controls (N = 20 each). PD subjects with normal (PDN, MoCA 26–30, N = 6) and impaired (PDD, MoCA ≤ 25, N = 14) cognition were compared. The wavelet-transform based time-frequency algorithm assessed the instantaneous predominant frequency (IPF) at 60 ms intervals throughout entire recordings. We then determined the relative time spent by the IPF in the four standard EEG frequency bands (RTF) at each scalp location. The resting occipital rhythm (ROR) was assessed using standard power spectral analysis. Results: Comparing PD subjects to healthy controls, mean values are decreased for ROR and RTF-Beta, greater for RTF-Theta and similar for RTF-Delta and RTF-Alpha. In logistic regression models, arithmetic combinations of RTF values [e.g., (RTF-Alpha) + (RTF-Beta)/(RTF-Delta + RTF-Theta)] and RTF-Alpha values at occipital or parietal locations are most able to discriminate between PD and controls. A principal component (PC) from principal component analysis (PCA) using RTF-band values in all subjects is associated with PD status (p = 0.004, β = 0.31, AUC = 0.780). Its loadings show positive contribution from RTF-Theta at all scalp locations, and negative contributions from RTF-Beta at occipital, parietal, central, and temporal locations. Compared to cognitively normal PD subjects, cognitively impaired PD subjects have lower median RTF-Alpha and RTF-Beta values, greater RTF-Theta values and similar RTF-Delta values. A PC from PCA using RTF-band values in PD subjects is associated with cognitive status (p = 0.002, β = 0.922, AUC = 0.89). Its loadings show positive contributions from RTF-Theta at all scalp locations, negative contributions from RTF-Beta at central locations, and negative contributions from RTF-Delta at central, frontal and temporal locations. Age, disease duration and/or sex are not significant covariates. No PC was associated with motor score or disease stage. Significance: Analyzing standard EEG recordings obtained in a community practice setting using a wavelet-based qEEG algorithm shows promise as a PD biomarker and for predicting cognitive impairment in PD. |
format | Online Article Text |
id | pubmed-8761986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87619862022-01-18 Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease Novak, Kevin Chase, Bruce A. Narayanan, Jaishree Indic, Premananda Markopoulou, Katerina Front Aging Neurosci Neuroscience Background: Quantitative electroencephalography (qEEG) has been suggested as a biomarker for cognitive decline in Parkinson’s disease (PD). Objective: Determine if applying a wavelet-based qEEG algorithm to 21-electrode, resting-state EEG recordings obtained in a routine clinical setting has utility for predicting cognitive impairment in PD. Methods: PD subjects, evaluated by disease stage and motor score, were compared to healthy controls (N = 20 each). PD subjects with normal (PDN, MoCA 26–30, N = 6) and impaired (PDD, MoCA ≤ 25, N = 14) cognition were compared. The wavelet-transform based time-frequency algorithm assessed the instantaneous predominant frequency (IPF) at 60 ms intervals throughout entire recordings. We then determined the relative time spent by the IPF in the four standard EEG frequency bands (RTF) at each scalp location. The resting occipital rhythm (ROR) was assessed using standard power spectral analysis. Results: Comparing PD subjects to healthy controls, mean values are decreased for ROR and RTF-Beta, greater for RTF-Theta and similar for RTF-Delta and RTF-Alpha. In logistic regression models, arithmetic combinations of RTF values [e.g., (RTF-Alpha) + (RTF-Beta)/(RTF-Delta + RTF-Theta)] and RTF-Alpha values at occipital or parietal locations are most able to discriminate between PD and controls. A principal component (PC) from principal component analysis (PCA) using RTF-band values in all subjects is associated with PD status (p = 0.004, β = 0.31, AUC = 0.780). Its loadings show positive contribution from RTF-Theta at all scalp locations, and negative contributions from RTF-Beta at occipital, parietal, central, and temporal locations. Compared to cognitively normal PD subjects, cognitively impaired PD subjects have lower median RTF-Alpha and RTF-Beta values, greater RTF-Theta values and similar RTF-Delta values. A PC from PCA using RTF-band values in PD subjects is associated with cognitive status (p = 0.002, β = 0.922, AUC = 0.89). Its loadings show positive contributions from RTF-Theta at all scalp locations, negative contributions from RTF-Beta at central locations, and negative contributions from RTF-Delta at central, frontal and temporal locations. Age, disease duration and/or sex are not significant covariates. No PC was associated with motor score or disease stage. Significance: Analyzing standard EEG recordings obtained in a community practice setting using a wavelet-based qEEG algorithm shows promise as a PD biomarker and for predicting cognitive impairment in PD. Frontiers Media S.A. 2022-01-03 /pmc/articles/PMC8761986/ /pubmed/35046794 http://dx.doi.org/10.3389/fnagi.2021.804991 Text en Copyright © 2022 Novak, Chase, Narayanan, Indic and Markopoulou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Novak, Kevin Chase, Bruce A. Narayanan, Jaishree Indic, Premananda Markopoulou, Katerina Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease |
title | Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease |
title_full | Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease |
title_fullStr | Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease |
title_full_unstemmed | Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease |
title_short | Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease |
title_sort | quantitative electroencephalography as a biomarker for cognitive dysfunction in parkinson’s disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761986/ https://www.ncbi.nlm.nih.gov/pubmed/35046794 http://dx.doi.org/10.3389/fnagi.2021.804991 |
work_keys_str_mv | AT novakkevin quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease AT chasebrucea quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease AT narayananjaishree quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease AT indicpremananda quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease AT markopouloukaterina quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease |